Abstract
Due to the severity and high prevalence of allergic diseases, there is growing interest in the development of inhibitors of such conditions. 3-Arylcoumarin derivatives emerge as promising compounds for the treatment of allergic disorders, in particular due to their close structural similarity to flavonoids, whose anti-allergic activity has been extensively reported. The aim of this work was to perform a screening of a set of 3-arylcoumarins as potential inhibitors of mast cell degranulation, a key event for the development of allergic reactions. For that purpose, it was utilized a biosensor model based on mast cells, whose in vitro assay allows for such screening, in a high throughput fashion, and also permits bringing to attention some coumarin structural features that are important for their biological activity. The mast cell-based biosensor was shown to discriminate, with high sensitivity and reproducibility, between coumarins that did not affect or caused different degrees of inhibition of degranulation. Among active coumarins, some substituents could be accounted for their inhibitory activity, such as the hydroxylation of positions 6 and 2′ of 3-phenylcoumarins, in addition to catechol, amino and thiophene moieties. In summary, 3-arylcoumarins could be suggested as potential candidates for the development of new anti-allergic drugs.
Similar content being viewed by others
References
Andrioli, W.J., M.S. Santos, V.B. Silva, R.B. Oliveira, A. Chagas-Paula, J.A. Jorge, N.A. Furtado, M.T. Pupo, C.H. Silva, R.M. Naal, and J.K. Bastos. 2012. δ-Lactam derivative from thermophilic soil fungus exhibits in vitro anti-allergic activity. Natural Product Research 26: 2168–2175.
Barsumian, E.L., C. Isersky, M.G. Petrino, and R.P. Siraganian. 1981. IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. European Journal of Immunology 11: 317–323.
Bissonnette, E.Y., G.M. Tremblay, V. Turmel, B. Pirotte, and M. Reboud-Rabaux. 2009. Coumarinic derivatives show anti-inflammatory effects on alveolar macrophages, but their anti-elastase activity is essential to reduce lung inflammation in vivo. International Immunopharmacology 9: 49–54.
Cheong, H., S.Y. Ryu, M.H. Oak, S.H. Cheon, G.S. Yoo, and K.M. Kim. 1998. Studies of structure activity relationship of flavonoids for the anti-allergic actions. Archives of Pharmacal Research 4: 478–480.
Choi, Y.H., and G.H. Yan. 2009. Anti-allergic effects of scoparone on mast cell-mediated allergy model. Phytomedicine 16: 1089–1094.
Curtis, T., R.M.Z.G. Naal, C. Batt, J. Tabb, and D. Holowka. 2008. Development of a mast cell-based biosensor. Biosensors & Bioelectronics 23: 1024–1031.
Hardy, R. 1986. Handbook of Experimental Immunology. Oxford: London.
Hong, J., H. Sasaki, N. Hirasawa, K. Ishihara, J.H. Kwak, O. Zee, F.J. Schmitz, T. Seyama, and K. Ohuchi. 2009. Suppresion of the antigen-stimulated RBL-2H3 mast cell activation by Artekeiskeanol A. Planta Medica 14: 1494–1498.
Hoult, J.R., and M. Payá. 1996. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. General Pharmacology 27: 713–722.
Huber, R., F.C. Stintzing, D. Briemle, C. Beckmann, U. Meyer, and C. Gründemann. 2012. In vitro antiallergic effects of aqueous fermented preparations from Citrus and Cydonia fruits. Planta Medica 78: 334–340.
Kabeya, L.M., C.H. da Silva, A. Kanashiro, J.M. Campos, A.E. Azzolini, A.C. Polizello, M.T. Pupo, and Y.M. Lucisano-Valim. 2008. Inhibition of immune complex-mediated neutrophil oxidative metabolism: a pharmacophore model for 3-phenylcoumarin derivatives using GRIND-based 3D-QSAR and 2D-QSAR procedures. European Journal of Medicinal Chemistry 43: 996–1007.
Kabeya, L.M., A.A. de Marchi, A. Kanashiro, N.P. Lopes, C.H. da Silva, M.T. Pupo, and Y.M. Lucisano-Valim. 2007. Inhibition of horseradish peroxidase catalytic activity by new 3-phenylcoumarin derivatives: synthesis and structure-activity relationships. Bioorganic & Medicinal Chemistry 15: 1516–1524.
Kambayashi, T., and G.A. Koretzky. 2007. Proximal signaling events in Fc epsilon RI-mediated mast cell activation. The Journal of Allergy and Clinical Immunology 119: 544–552.
Kang, K.H., C.S. Kong, Y. Seo, M.M. Kim, and S.K. Kim. 2009. Anti-inflammatory effect of coumarins isolated from Corydalis heterocarpa in HT-29 human colon carcinoma cells. Food and Chemical Toxicology 47: 2129–2134.
Kim, J.W., J.H. Lee, B.Y. Hwang, S.H. Mun, N.Y. Ko, K. Kim, B. Kim, H.S. Kim, Y.M. Kim, and W.S. Choi. 2009. Morin inhibits Fyn kinase in mast cell and IgE-mediated type I hypersensitivity response in vivo. Biochemical Pharmacology 77: 1506–1512.
Kontogiorgis, C., and D. Hadjipavlou-Litina. 2003. Biological evaluation of several coumarin derivatives designed as possible anti-inflammatory/antioxidant agents. Journal of Enzyme Inhibition and Medicinal Chemistry 18: 63–69.
Kostova, I., Raleva, S., Genova, P., Argirova, R., (2006). Structure-activity relationships of synthetic coumarins as HIV inhibitors. Bioinorganic Chemistry and Applications 2006: Article ID 68274.
Joo, S.S., D. Park, S. Shin, J.H. Jeon, T.K. Kim, Y.J. Choi, S.H. Lee, J.S. Kim, S.K. Park, B.Y. Hwang, B.Y. Lee, and Y.B. Kim. 2010. Anti-allergic effects and mechanisms of action of the ethanolic extract of Angelica gigas in dinitrofluorobenzene-induced inflammation models. Environmental Toxicology and Pharmacology 30: 127–133.
Lambiase, A., A. Micera, and S. Bonini. 2009. Multiple action agents and the eye: do they really stabilize mast cells? Current opinion in Allergy and Clinical Immunology 9: 454–465.
de Marchi, A.A., M.S. Castilho, P.G. Nascimento, F.C. Archanjo, G. del Ponte, G. Oliva, and M.T. Pupo. 2004. New 3-piperonylcoumarins as inhibitors of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) from Trypanosoma cruzi. Bioorganic & Medicinal Chemistry 12: 4823–4833.
Masuda, E.S., and J. Schmitz. 2008. Syk inhibitors as treatment for allergic rhinitis. Pulmonary Pharmacology & Therapeutics 21: 461–467.
Matsuda, H., T. Morikawa, H. Managi, and M. Yoshikawa. 2003. Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids forinhibition of degranulation and release of TNF-alpha and IL-4 in RBL-2H3 cells. Bioorganic & Medicinal Chemistry Letters 13: 3197–3202.
Mastuda, H., T. Morikawa, K. Ueda, H. Managi, and M. Yoshikawa. 2002. Structural requirements of flavonoids for inhibition of antigen-Induced degranulation, TNF-alpha and IL-4 production from RBL-2H3 cells. Bioorganic & Medicinal Chemistry 10: 3123–3128.
Melagraki, G., A. Afantitis, O. Igglessi-Markopoulou, A. Detsi, M. Koufaki, C. Kontogiorgis, and D.J. Hadjipavlou-Litina. 2009. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts. European Journal of Medicinal Chemistry 44: 3020–3026.
Metzger, H. 1992. The receptor with high affinity for IgE. Immunological Reviews 125: 37–48.
Mishra, R., K.K. Jha, S. Kumar, and I. Tomer. 2011. Synthesis, properties and biological activity of thiophene: a review. Der Pharma Chemica 3: 38–54.
Moon, P.D., B.H. Lee, H.J. Jeong, H.J. An, S.J. Park, H.R. Kim, S.G. Ko, J.Y. Um, S.H. Hong, and H.M. Kim. 2007. Use of scopoletin to inhibit the production of inflammatory cytokines through inhibition the IkappaB/NF-kappaB signal cascade in the human mast cell line HMC-1. European Journal of Pharmacology 555: 218–225.
Moriya, K., J. Rivera, S. Odom, Y. Sakuma, K. Muramato, T. Yoshiuchi, M. Miyamoto, and K. Yamada. 1997. ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of Fcε receptor I-mediated activation of Syk. Proceedings of the National Academy of Sciences of the United States of America 94: 12539–12544.
Naal, R.M.Z.G., J. Tabb, D. Holowka, and B. Baird. 2004. In situ measurement of degranulation as a biosensor based on RBL-2H3 mast cells. Biosensors & Bioelectronics 20: 791–796.
Nakano, N., C. Nishiyama, T. Tokura, Y. Nagasako-Akazome, Y. Ohtake, K. Okumura, and H. Ogawa. 2008. Procyanidin C1 from apple extracts inhibits Fc epsilon RI-mediated mast cell activation. International Archives of Allergy and Immunology 147: 213–221.
Pedersen, J.Z., C. Oliveira, S. Incerpi, V. Kumar, A.M. Fiore, P. De Vito, A.K. Prasad, S.V. Malhotra, V.S. Parmar, and L. Saso. 2007. Antioxidant activity of 4-methylcoumarins. Journal of Pharmacy and Pharmacology 59: 1721–1728.
Posner, R.G., B. Lee, D.H. Conrad, D. Holowka, B. Baird, and B. Goldstein. 1992. Aggregation of IgE-receptor complexes on rat basophilic leukemia cells does not change the intrinsic affinity but can alter the kinetics of the ligand-IgE interaction. Biochemistry 31: 5350–5356.
Riveiro, M.E., N. De Kimpe, A. Moglioni, R. Vázquez, F. Monczor, C. Shayo, and C. Davio. 2010. Coumarins: old compounds with novel promising therapeutic perspectives. Current Medicinal Chemistry 17: 1325–1338.
Rossi, A.B., E. Herlaar, S. Braselmann, S. Huynh, V. Taylor, R. Frances, S.D. Issakani, A. Argade, R. Singh, D.G. Payan, and E. Masuda. 2006. Identification of the Syk kinase inhibitor R112 by a human mast cell screen. Journal of Allergy and Clinical Immunology 118: 749–755.
Ryu, S.Y., N.Y. Kou, H.S. Choi, H. Ryu, T.S. Kim, and K.M. Kim. 2001. Cnidicin, a coumarin, from the root of Angelica koreana, inhibits the degranulation of mast cell and the NO generation in RAW 264.7 cells. Planta Medica 67: 172–174.
Serna, H., M. Porras, and P. Vergara. 2006. Mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4 h-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat. Journal of Pharmacology and Experimental Therapeutics 319: 1104–1111.
Smyth, T., V.N. Ramachandran, and W.F. Smyth. 2009. A study of the antimicrobial activity of selected naturally occurring and synthetic coumarins. International Journal of Antimicrobial Agents 33: 421–426.
Tanifuji, S., E. Aizu-Yokota, M. Funakoshi-Tago, Y. Sonoda, H. Inoue, and T. Kasahara. 2010. Licochalcones suppress degranulation by decreasing the intracellular Ca2+ level and tyrosine phosphorylation of ERK in RBL-2H3 cells. International Immunopharmacology 10: 769–776.
Waffo, A.K., G.A. Azebaze, A.E. Nkengfack, Z.T. Fomum, M. Meyer, B. Bodo, and F.R. van Heerden. 2000. Indicanines B and C, two isoflavonoid derivatives from the root bark of Erythrina indica. Phytochemistry 53: 981–985.
Wang, Q., H. Matsuda, K. Matsuhira, S. Nakamura, D. Yuan, and M. Yoshikawa. 2007. Inhibitory effects of thunberginols A, B, and F on degranulations and releases of TNF-alpha and IL-4 in RBL-2H3 cells. Biological & Pharmaceutical Bulletin 30: 388–392.
Wu, L., X. Wang, W. Xu, F. Farzaneh, and R. Xu. 2009. The structure and pharmacological functions of coumarins and their derivatives. Current Medicinal Chemistry 16: 4236–4260.
Acknowledgments
The authors thank Drs. Barbara Baird and David Holowka (Cornell University) for the kind gifts: DNP-BSA and anti-DNP IgE. This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), grant # 1277/10-3, Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), grant # 2008/01712-6 and Instituto Nacional de Ciência e Tecnologia de Bioanalítica. MTP also thanks Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for grant fellowship.
Conflict of interest
The authors declare they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Souza Santos, M., Freire de Morais Del Lama, M.P., Deliberto, L.A. et al. In situ screening of 3-arylcoumarin derivatives reveals new inhibitors of mast cell degranulation. Arch. Pharm. Res. 36, 731–738 (2013). https://doi.org/10.1007/s12272-013-0084-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-013-0084-8